No products in the cart.

Chapter 17: Drugs Affecting the Respiratory System

Pharmacotherapeutics for Nurse Practitioner Prescribers 3rd Edition by Teri Moser Woo

$2.99

Chapter 17: Drugs Affecting the Respiratory System

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

Multiple Choice

Identify the choice that best completes the statement or answers the question.

 

____     1.   Digoxin levels need to be monitored closely when the following medication is started:

A. Loratadine
B. Diphenhydramine
C. Ipratropium
D. Albuterol

 

 

____     2.   Patients with pheochromocytoma should avoid which of the following classes of drugs due to the possibility of developing hypertensive crisis?

A. Expectorants
B. Beta-2-agonists
C. Antitussives
D. Antihistamines

 

 

____     3.   Harold, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all?

A. Betamethasone, an inhaled corticosteroid
B. Salmeterol, an inhaled long-acting beta-agonist
C. Albuterol, a short-acting beta-agonist
D. Montelukast, a leukotriene modifier

 

 

____     4.   Long-acting beta-agonists (LTBAs) received a Black Box warning from the U.S. Food and Drug Administration due to the:

A. Risk of life-threatening dermatological reactions
B. Increased incidence of cardiac events when LTBAs are used
C. Increased risk of asthma-related deaths when LTBAs are used
D. Risk for life-threatening alterations in electrolytes

 

Answer Section

 

MULTIPLE CHOICE

 

  1. ANS:  D                    PTS:   1

 

  1. ANS:  B                    PTS:   1

 

  1. ANS:  B                    PTS:   1

 

  1. ANS:  C                    PTS:   1

Additional information

Add Review

Your email address will not be published. Required fields are marked *